# OnCo record paper-convert-lancet-oncol-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-convert-lancet-oncol-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-convert-lancet-oncol-2017" ;
  schema:name "Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial"@en ;
  schema:description "Published report from the CONVERT trial registered as NCT00433563, in The Lancet Oncology (2017), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-convert-lancet-oncol-2017/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(17)30318-2>, <https://pubmed.ncbi.nlm.nih.gov/28642008/>, <https://europepmc.org/article/MED/28642008>, <https://clinicaltrials.gov/study/NCT00433563> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(17)30318-2> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Faivre-Finn C, Snee M, Ashcroft L, et al." ;
  onco:trials <https://onco.cc/trials/convert/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .